Access to HCPs is tough - that's not news to anyone who has spent more than a few years in this industry. But how pharma organizations are using their access varies widely and can create a competitive edge. Connected engagement models are allowing commercial organizations to make the most of the time they have with HCPs, strengthening relationships and keeping doors open. Pharmaceutical Executive, thanks for having me to share my thoughts on this topic. https://lnkd.in/gbu2XfNA
Dan Rizzo’s Post
More Relevant Posts
-
Clinical trials are the backbone of medical research and the impetus behind many new, innovative drugs and therapies. Yet, clinical trials can be very long and tedious, leading to low rates of trial participation and retention. According to The National Institutes of Health, 11% of clinical research sites fail to enroll even a single participant and 37% of sites are under-enrolling. Traditional clinical trial designs have failed to address this issue and are often inundated with recruitment and retention challenges because they overlook patient preferences, like at-home drug administration and data collection. Clinical trial leaders can help solve the problem of patient recruitment, engagement, and retention, by thoughtfully incorporating patient optionality and new technology into clinical trials. By leading with a patient-centric mindset and offering a patient more options, whilst leveraging the latest technologies, we can truly create a more personalized, inclusive, and seamless patient experience for all. Full article posted to Pharmaceutical Outsourcing #clinicaltrials #research #technology #healthcare Read more: https://lnkd.in/gYT49m6Z
Providing Patients the Power of Choice: The Value of Patient Optionality
pharmoutsourcing.com
To view or add a comment, sign in
-
EU Champions Real-World Evidence in Healthcare: Horizon Europe Funds Projects to Revolutionize Decision-Making The European Union is leading efforts to integrate real-world evidence (RWE) and advanced data analytics into healthcare decision-making through five projects funded under the Horizon Europe program. These projects aim to enhance regulatory decision-making and health technology assessments in various health sectors, including drug development, diabetes care, medical device software, and cancer therapy evaluation. The goal is to improve healthcare outcomes by making decisions more data-driven and reliable, with collaboration and innovative technologies like AI playing a crucial role. The projects are expected to achieve their objectives by 2026 and demonstrate the value of RWE in transforming healthcare decision-making. For more details please click the link! https://lnkd.in/dYch2_VJ #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical
EU Champions Real-World Evidence in Healthcare: Horizon Europe Funds Projects to Revolutionize Decision-Making
https://marketaccesstoday.com
To view or add a comment, sign in
-
Are you interested in understanding the recent decline in HCP access and how Pharmaceutical companies are finding ways to extend HCP relationships?
Veeva Pulse Field Trends Report | Veeva
veeva.com
To view or add a comment, sign in
-
Breaking down financial barriers in clinical trials is key to enhancing equity and access for patients. Cloudbyz explores solutions to address costs and ensure comprehensive support. Learn how financial assistance programs can increase diversity and participation. Learn more: https://hubs.li/Q02zN0pr0 To learn more book a meeting here: Connect at https://hubs.li/Q02zM_Ks0 #DataCapture #CTMS #eTMF #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials
Breaking Down Financial Barriers in Clinical Trials: Enhancing Equity and Access for Patients
https://www.cloudbyz.com/resources
To view or add a comment, sign in
-
Breaking down financial barriers in clinical trials is key to enhancing equity and access for patients. Cloudbyz explores solutions to address costs and ensure comprehensive support. Learn how financial assistance programs can increase diversity and participation. Learn more: https://hubs.li/Q02zN19T0 To learn more book a meeting here: Connect at https://hubs.li/Q02zM_GJ0 #DataCapture #CTMS #eTMF #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials
Breaking Down Financial Barriers in Clinical Trials: Enhancing Equity and Access for Patients
https://www.cloudbyz.com/resources
To view or add a comment, sign in
-
CEO | Next-Gen Unified Clinical Trials Management on Salesforce | AI | CTMS | CTBM | eTMF | EDC | RTSM | Safety & PV
Breaking down financial barriers in clinical trials is key to enhancing equity and access for patients. Cloudbyz explores solutions to address costs and ensure comprehensive support. Learn how financial assistance programs can increase diversity and participation. Learn more: https://hubs.li/Q02zN19V0 To learn more book a meeting here: Connect at https://hubs.li/Q02zM_GK0 #DataCapture #CTMS #eTMF #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials
Breaking Down Financial Barriers in Clinical Trials: Enhancing Equity and Access for Patients
https://www.cloudbyz.com/resources
To view or add a comment, sign in
-
The 3 Key Reasons Why MSLs Are Vitally Important in HCP KOL Recruitment Discover the Power of MSLs in HCP Recruitment! Unearth three key reasons why Medical Science Liaisons are crucial in engaging Key Opinion Leaders. Nooma Group brings you pivotal insights for your Pharma strategy. #MSLs #HCPRecruitment #PharmaStrategy
The 3 key reasons why MSLs are vitally important in HCP/KOL recruitment - Nooma Group Consulting
https://www.noomagroup.com
To view or add a comment, sign in
-
Breaking down financial barriers in clinical trials is key to enhancing equity and access for patients. Cloudbyz explores solutions to address costs and ensure comprehensive support. Learn how financial assistance programs can increase diversity and participation. Learn more: https://hubs.li/Q02zN0pq0 To learn more book a meeting here: Connect at https://hubs.li/Q02zN0r90 #DataCapture #CTMS #eTMF #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials
Breaking Down Financial Barriers in Clinical Trials: Enhancing Equity and Access for Patients
https://www.cloudbyz.com/resources
To view or add a comment, sign in
-
“Unlocking New Insights: The Promise of Real-World Data and Real-World Evidence in Advancing Clinical Research" explores how #RWD and #RWE revolutionize healthcare by bridging theory and practice, driving evidence-based decision-making and transforming the clinical research landscape: https://lnkd.in/dsvmUQvj #Octalsoft #RealWorldData #RealWorldEvidence #ClinicalTrials #Healthcare #Pharma #ClinicalResearch #PharmaceuticalIndustry #HealthcareIndustry #CRO
Unlocking the Value of RWD (Real-World Data) and RWE (Real-World Evidence) in Modern Clinical Trials
https://www.octalsoft.com
To view or add a comment, sign in
-
https://lnkd.in/esizaRzr The Participant Engagement Award, initiated in 2016, serves as a platform to recognize and celebrate innovative efforts within the clinical research industry aimed at enhancing participant engagement and comprehension. This award underscores the significance of fostering meaningful connections with research participants, acknowledging that their active involvement is crucial for the success of clinical studies. #research #artificalintelligence #AI #technology #clinicalresearch #drugdevelopment #pharmacovigilance #conferences #esclinicalresearchgroup #clinicaltrial #clinicaltrials #regulatoryaffairs #informatics #drugdiscovery #drugsafety #clinical #clinicaldevelopment #clinicaloperations #software #pharmaceuticals #biotechnology #software #bioinformatics
Participant Engagement Award Finalists Named for 2024
clinicalresearchnewsonline.com
To view or add a comment, sign in